Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

AstraZeneca plans new R&D hub in Kendall Square
Pharmaforum
Fri, 04/29/22 - 10:47 am
Tags:
AstraZeneca, R&D, Cambridge MA, Kendall Square, earnings
AstraZeneca's Ultomiris scores its 3rd FDA approval, setting up market clash with argenx
Fierce Pharma
Thu, 04/28/22 - 11:05 am
Tags:
AstraZeneca, Ultomiris, FDA, myasthenia gravis
AstraZeneca staves off last Tagrisso copycat with settlement—for now
Fierce Pharma
Wed, 04/27/22 - 10:40 pm
Tags:
AstraZeneca, Tagrisso, patents, legal, Alembic Pharmaceuticals, generics
Late-stage pain pipeline refuses to swell
EP Vantage
Tue, 04/26/22 - 10:29 pm
Tags:
painkillers, Vertanical, Teva Pharmaceutical, Regeneron, Ampio Pharmaceuticals, Biogen, Eli Lilly, Vertex Pharmaceuticals, AstraZeneca, Acadia Pharmaceuticals
After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA
Endpoints
Mon, 04/25/22 - 10:20 am
Tags:
AstraZeneca, FDA, tremelimumab, liver cancer, priority review
AstraZeneca says no severe virus cases or deaths after taking antibody
Morningstar
Thu, 04/21/22 - 10:51 am
Tags:
AstraZeneca, Evusheld, COVID-19, antibodies
AstraZeneca Pushes Deeper into CDx Space with New Collaboration
Medical Devices and Diagnostics Industry
Wed, 04/20/22 - 11:09 am
Tags:
Medtech, diagnostics, CDx, companion diagnostics, prostate cancer, AstraZeneca, Amoy Diagnostics
Outside of big pharma, life remains tough for listed developers
EP Vantage
Wed, 04/20/22 - 10:38 am
Tags:
pharma stocks, AbbVie, AstraZeneca, BeiGene, BioNTech, Moderna Therapeutics, Pfizer, Roche
FDA starts speedy review of Enhertu in lung cancer
Pharmaforum
Tue, 04/19/22 - 10:54 am
Tags:
AstraZeneca, Daiichi Sankyo, FDA, non-small cell lung cancer, Enhertu
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven
Fierce Biotech
Mon, 04/18/22 - 10:48 am
Tags:
AstraZeneca, Alexion, Arvinas, Connecticut
AstraZeneca bets $25M on preclinical bispecific against hot target, docking in Chinese Harbour to land global rights
Fierce Biotech
Thu, 04/7/22 - 11:16 am
Tags:
AstraZeneca, Harbour BioMed, bispecifics
ACC 2022 – Astra’s cholesterol lowerer surprise comes just a little late
EP Vantage
Tue, 04/5/22 - 10:59 am
Tags:
AstraZeneca, Ionis Pharmaceuticals, AZD8233, cholesterol, ACC, Amgen, Sanofi, Novartis, Regeneron
AACR Preview: AstraZeneca to Showcase "Oncology Revolution"
BioSpace
Mon, 03/28/22 - 07:48 pm
Tags:
AstraZeneca, oncology, AACR
AstraZeneca's Imfinzi Fails to Boost Survival in Cervical Cancer
BioSpace
Thu, 03/24/22 - 11:44 am
Tags:
AstraZeneca, Imfinizi, cervical cancer, clinical trials
AstraZeneca doubles down on digital health in its latest collaboration
Endpoints
Wed, 03/23/22 - 10:53 pm
Tags:
AstraZeneca, digital health, Huma Therapeutics, decentralized clinical trials
AstraZeneca antibody drug effective against BA.2, study finds
Beckers Hospital Review
Mon, 03/21/22 - 10:37 pm
Tags:
AstraZeneca, Evusheld, Omicron variant, Omicron BA.2, COVID-19
Bristol Myers sues AstraZeneca over cancer-treatment patents
Reuters
Mon, 03/21/22 - 10:08 am
Tags:
Bristol Myers Squibb, AstraZeneca, cancer, patents, legal
AstraZeneca prepared to ditch effort to secure US approval for Covid vaccine
Financial Times
Thu, 03/17/22 - 11:35 pm
Tags:
AstraZeneca, vaccines, COVID-19
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Fierce Pharma
Thu, 03/17/22 - 10:38 am
Tags:
AstraZeneca, Roche, Chugai, Ultomiris, patents
AstraZeneca throws open doors to new ideas in global postdoc challenge
Fierce Biotech
Thu, 03/17/22 - 10:32 am
Tags:
AstraZeneca, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.